Glinil-M Tablet: Dual Action Diabetes Management

Glinil-M Tablet combines the potent glycemic control of glibenclamide (5mg) with the established effectiveness of metformin (500mg), a dual-action approach for effective diabetes management.

This combination tablet is specifically designed for adults with Type 2 Diabetes Mellitus who require supplemental assistance to regulate blood glucose levels. Both glibenclamide and metformin act independently, contributing to improved glycemic control:

* Glibenclamide targets the pancreatic beta cells to increase insulin release, while also inhibiting the activity of other hormones that raise blood sugar.
* Metformin works primarily by reducing hepatic glucose production, enhancing insulin sensitivity, and slowing down the absorption of glucose from the intestines.

Glinil-M is a convenient, once-daily dosage option for patients seeking to achieve sustained control over their blood sugar levels. Always consult with your healthcare professional regarding dosages and suitability.

Note: This information is not a substitute for medical advice. Consult a physician or qualified health care provider before starting any new medication regimen.